Clebopride malate
CAS No. 57645-91-7
Clebopride malate( —— )
Catalog No. M20810 CAS No. 57645-91-7
Clebopride malate is a dopamine antagonist drug?Used to treat functional gastrointestinal disorders such as nausea or vomiting.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 42 | Get Quote |
|
10MG | 60 | Get Quote |
|
25MG | 95 | Get Quote |
|
50MG | 132 | Get Quote |
|
100MG | 222 | Get Quote |
|
200MG | 331 | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameClebopride malate
-
NoteResearch use only, not for human use.
-
Brief DescriptionClebopride malate is a dopamine antagonist drug?Used to treat functional gastrointestinal disorders such as nausea or vomiting.
-
DescriptionClebopride malate is a dopamine antagonist drug?Used to treat functional gastrointestinal disorders such as nausea or vomiting.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetDopamine Receptor
-
RecptorDopamine
-
Research AreaMetabolic Disease
-
IndicationGastroesophageal reflux and functional dyspepsia
Chemical Information
-
CAS Number57645-91-7
-
Formula Weight507.96
-
Molecular FormulaC24H30ClN3O7
-
Purity>98% (HPLC)
-
SolubilityDMSO:34 mg/mL (66.93 mM)
-
SMILESCOc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1.O=C(O)CC(O)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bleiberg H Piccart M Lips S et al. A phase I trial of a new antiemetic drug--clebopride malate--in cisplatin-treated patients[J]. Annals of Oncology Official Journal of the European Society for Medical Oncology 1992 3(2):141.
molnova catalog
related products
-
(+)-PD 128907 hydroc...
(+)-PD 128907 hydrochloride is an agonist of D3 dopamine receptor .
-
GSK598809
GSK598809 (GSK-598809) is a potent, selective, CNS penetrant and orally bioavailable dopamine D3 receptor antagonist with pKi of 8.9; displays >100-fold selectivity over D2 and H1 receptors.
-
SB-277011
A potent and selective dopamine D3 receptor antagonist with pKi of 8.0.